Cost-effectiveness of the rational use of myocardial perfusion imaging in stable coronary artery disease
China has the highest mortality rate from cardiovascular disease in the world and coro-nary artery disease(CAD)is the leading cause of death from cardiovascular disease.The cost of treatment for CAD is high,which is related to the incidence of CAD and possible irrational treatment protocols.How-ever,with the escalating costs of healthcare in most countries,the cost-effectiveness of diagnostic and man-agement testing is increasingly important.Many studies have shown that most non-invasive tests are more cost-effective than coronary angiography(CAG).This article reviews the cost-effectiveness of MPI compared with CAG and other non-invasive tests.